Concepedia

Author

Kana Miyatake

Kōchi University

Also Known As

K Miyatake, K. Miyatake, KANA MIYATAKE, Kana MIYATAKE, Kana Miyatake, Miyatake K

37

Publications

186

Citations

7

H-Index

15

Concepts

All Affiliations

Kōchi UniversityKochi Medical School Hospital
KM

About

Kana Miyatake is an author at Kōchi University specializing in medical imaging, nuclear medicine, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Engineering

2

2

33

2

Biomedical Imaging

2

2

33

3

Health Sciences

1

1

16

4

Medicine

1

1

17

5

Pathology

1

1

17

Kana Miyatake

×

7

Publications

124

Citations

7

H-Index

YearCitations

New radiosensitization treatment (KORTUC I) using hydrogen peroxide solution-soaked gauze bolus for unresectable and superficially exposed neoplasms

T Inomata, Shigetoshi Sano, Mitsunori Ikeda,

Oncology Reports

2008

39

Diffusion-weighted magnetic resonance imaging for assessment after neoadjuvant chemotherapy in breast cancer, based on morphological concepts

Yoriko Murata, Kei Kubota, Norihiko Hamada,

Oncology Letters

2010

17

Safety and efficacy of image-guided enzyme-targeting radiosensitization and intraoperative radiotherapy for locally advanced unresectable pancreatic cancer

Akihito Nishioka, Yasuhiro Ogawa, Kana Miyatake,

Oncology Letters

2014

17

18F FDG-PET/CT analysis of spread through air spaces (STAS) in clinical stage I lung adenocarcinoma

Miki Nishimori, Hitomi Iwasa, Kana Miyatake,

Annals of Nuclear Medicine

2022

16

Therapeutic response to a novel enzyme-targeting radiosensitization treatment (Kochi Oxydol-Radiation Therapy for Unresectable Carcinomas) in patients with recurrent breast cancer

N. Aoyama, Yasuhiro Ogawa, Miki Yasuoka,

Oncology Letters

2016

12

Therapeutic response to a novel enzyme-targeting radiosensitization treatment (KORTUC II) for residual lesions in patients with stage IV primary breast cancer, following induction chemotherapy with epirubicin and cyclophosphamide or taxane

N. Aoyama, Yasuhiro Ogawa, Miki Yasuoka,

Oncology Letters

2016

12

Therapeutic results of a novel enzyme-targeting radiosensitization treatment, Kochi oxydol-radiation therapy for unresectable carcinomas II, in patients with stage I primary breast cancer

N. Aoyama, Yasuhiro Ogawa, Miki Yasuoka,

Oncology Letters

2017

11

Page 1